Anti-CD20 therapy (unspecified maintenance vs de-escalation)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD20 therapy (unspecified maintenance vs de-escalation), covering 2025-09-23 to 2025-09-23. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis [Phase 3]